What Parents Should Expect During a Child’s Medication Assessment and Review

When medication is being considered for a child or young person, parents often have questions about the assessment process, possible benefits, side effects and what happens after treatment begins. Medication should not be viewed as a quick or isolated solution. It is one part of a broader care plan that may also include psychological support, educational adjustments, parenting guidance and help with emotional or behavioural difficulties.

At Healing Young Minds LTD, our Medication Assessment, Initiation & Review service provides careful, individualised assessment and follow-up for children and young people. Our approach follows appropriate NICE-guideline diagnostic and treatment pathways, with decisions made collaboratively with the child or young person and their parents or carers.

When might a medication assessment be recommended?

A medication assessment may be considered following a comprehensive psychiatric or neurodevelopmental assessment. This may be relevant where a child or young person has ADHD, autism alongside significant associated difficulties, anxiety, depression, obsessive-compulsive symptoms, sleep problems or other mental health conditions.

Medication is not automatically appropriate. The clinician will consider the child’s diagnosis, symptoms, level of distress or impairment, developmental stage, physical health, current circumstances and previous support. For some children, psychological or behavioural approaches, environmental changes or school-based support may be recommended before medication. In other situations, medication may be appropriate alongside these interventions.

The assessment is also an opportunity to consider whether symptoms could be caused or worsened by another issue, such as sleep difficulties, physical illness, learning needs, family stress or an unrecognised mental health condition. A clear understanding of the whole child is important before treatment is started.

What happens during the assessment?

The clinician will begin by listening to the concerns that led to the referral and exploring the child’s current difficulties. This may include attention, impulsivity, mood, anxiety, behaviour, sleep, appetite, relationships, school or college functioning and day-to-day independence.

Information may be gathered from several sources, depending on the child’s age and circumstances. This can include the child or young person, parents or carers, school or college reports, previous assessments and other professionals involved in their care. The child’s own views are important, and the clinician will aim to speak with them in an age-appropriate way.

The assessment may cover:

Current symptoms, their duration and their impact at home, in education and socially.
Previous and current treatments, including prescribed medication, over-the-counter products and supplements.
Medical history, allergies, physical health, sleep, appetite and growth.
Family medical and mental health history where relevant.
Any concerns about substance use, self-harm, suicidal thoughts, safeguarding or risk.
The child’s strengths, interests, relationships and goals for treatment.

For some medicines, baseline physical health checks will be needed. These may include height, weight, pulse and blood pressure, alongside other checks where clinically indicated. The clinician will explain which assessments are relevant and whether information from the child’s GP or another professional is required.

Discussing the options

Once the assessment is complete, the clinician will explain whether medication is recommended and why. This discussion should include the expected benefits, possible disadvantages, alternatives and the uncertainties involved. There may be more than one reasonable option, and a decision does not usually need to be rushed unless there is an urgent clinical concern.

Medication choices depend on the condition being treated. For example, ADHD medicines are selected according to the child’s symptoms, overall health, age, previous response and preferences. Medication used for anxiety, depression, severe emotional distress or other mental health conditions requires equally careful consideration and monitoring. Medicines are prescribed within their licensed indications where possible; if an unlicensed or off-label use is considered, this should be explained clearly.

The clinician will discuss how the medicine is taken, when effects might be noticed, how long a trial may last and what to do if a dose is missed. Parents should feel able to ask practical questions, including how medication may fit around school, meals, sleep, sports, holidays and other prescribed treatments.

Consent and the child’s involvement

Consent is a central part of medication treatment. Parents or those with parental responsibility will usually be involved in decisions for younger children. Children and young people should also be given information in a way they can understand and supported to express their views.

As children mature, their ability to understand and make decisions about treatment becomes increasingly important. The clinician will consider the young person’s capacity to consent and will involve them as fully as possible. Even where a parent or carer provides consent, treatment is more likely to be successful when the child or young person understands its purpose and feels listened to.

Before prescribing, the clinician will also check for any legal, safeguarding or practical issues that may affect treatment. Families should tell the clinician about all medicines and supplements, including those prescribed by another service.

Starting medication safely

If medication is agreed, it is commonly started at a low dose and adjusted cautiously according to response and tolerability. The exact plan depends on the medicine and the child’s clinical circumstances. Families will receive information about common side effects and symptoms that should prompt urgent medical advice.

Possible side effects vary between medicines. Depending on the treatment, these may include changes in appetite, sleep, mood, anxiety, stomach discomfort, headaches, tiredness, agitation or changes in blood pressure or pulse. A side effect is not always a reason to stop treatment, but it should be reported so that the clinician can decide whether to adjust the dose, change the timing, pause treatment or consider an alternative.

Parents should not change the dose or stop a prescribed medicine without discussing this with the prescribing clinician, unless they have been given specific safety instructions to do so. If a child develops severe symptoms, an acute deterioration in mental health, an allergic reaction or immediate safety concerns, urgent medical help should be sought.

What happens during a medication review?

A review examines whether the medicine is helping and whether the benefits outweigh any unwanted effects. The timing will depend on the medicine, the child’s needs and the treatment plan. Early follow-up may be arranged after medication is started or a dose is changed, with further reviews once the treatment response is clearer.

During a review, the clinician may ask about:

Changes in the original symptoms and day-to-day functioning.
The child’s experience of treatment, including what they find helpful or difficult.
Appetite, eating patterns, sleep, mood and physical wellbeing.
School or college feedback, relationships and activities.
Physical measurements such as height, weight, pulse and blood pressure when relevant.
Adherence, missed doses, timing and any interactions with other treatments.

It can be helpful to keep a brief record between appointments. This might include when the medicine is taken, noticeable benefits, side effects, sleep, appetite and feedback from school. The purpose is not to monitor every detail anxiously, but to provide a balanced picture that supports informed decisions.

Making ongoing treatment decisions

Medication may be continued when it is providing meaningful benefit with acceptable side effects. The plan may be adjusted if the response is limited, side effects are troublesome or the child’s circumstances change. Options can include changing the dose, altering the timing, switching medicine, adding psychological or practical support, or stopping treatment in a planned way.

Reviews should also consider whether medication is still needed and whether a supervised reduction or treatment break is appropriate. This depends on the diagnosis, symptoms, risks and current functioning. Any change should be planned with the prescribing clinician and followed by appropriate monitoring.

How parents can prepare

Before an appointment, make a note of the main concerns, treatment goals and questions you would like answered. Bring an up-to-date list of medicines and supplements, and share relevant reports from school or other professionals. It is also useful to explain what the child or young person hopes will improve, as well as any worries they have about medication.

There is no expectation that parents will already know which medicine is suitable. The assessment is a space for careful discussion, balanced advice and shared decision-making.

Contact Healing Young Minds LTD

If you would like advice about medication assessment, initiation or review for your child or young person, please contact Healing Young Minds LTD. Our team can discuss your concerns, explain the assessment pathway and help you understand the next appropriate step.